RemeGen Statistics

Total Valuation

RemeGen has a market cap or net worth of CNY 49.28 billion. The enterprise value is 50.26 billion.

Market Cap	49.28B
Enterprise Value	50.26B

Important Dates

The next estimated earnings date is Saturday, March 28, 2026.

Earnings Date	Mar 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	355.70M
Shares Outstanding	n/a
Shares Change (YoY)	+0.77%
Shares Change (QoQ)	+4.08%
Owned by Insiders (%)	11.98%
Owned by Institutions (%)	26.14%
Float	337.07M

Valuation Ratios

The trailing PE ratio is 69.55 and the forward PE ratio is 85.80.

PE Ratio	69.55
Forward PE	85.80
PS Ratio	15.16
PB Ratio	21.24
P/TBV Ratio	22.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	70.93
EV / Sales	15.85
EV / EBITDA	54.09
EV / EBIT	71.41
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.94
Debt / EBITDA	2.29
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 32.91% and return on invested capital (ROIC) is 9.85%.

Return on Equity (ROE)	32.91%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	9.85%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	7.97%
Revenue Per Employee	1.08M
Profits Per Employee	236,253
Employee Count	3,070
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, RemeGen has paid 748,700 in taxes.

Income Tax	748,700
Effective Tax Rate	0.11%

Stock Price Statistics

The stock price has increased by +203.23% in the last 52 weeks. The beta is 0.74, so RemeGen's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+203.23%
50-Day Moving Average	94.22
200-Day Moving Average	82.27
Relative Strength Index (RSI)	48.32
Average Volume (20 Days)	5,326,316

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RemeGen had revenue of CNY 3.25 billion and earned 708.52 million in profits. Earnings per share was 1.29.

Revenue	3.25B
Gross Profit	3.25B
Operating Income	721.43M
Pretax Income	709.27M
Net Income	708.52M
EBITDA	952.44M
EBIT	721.43M
Earnings Per Share (EPS)	1.29

Full Income Statement

Balance Sheet

The company has 1.18 billion in cash and 2.18 billion in debt, giving a net cash position of -1.00 billion.

Cash & Cash Equivalents	1.18B
Total Debt	2.18B
Net Cash	-1.00B
Net Cash Per Share	n/a
Equity (Book Value)	2.32B
Book Value Per Share	4.20
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 22.19% and 21.79%.

Gross Margin	100.00%
Operating Margin	22.19%
Pretax Margin	21.82%
Profit Margin	21.79%
EBITDA Margin	29.30%
EBIT Margin	22.19%
FCF Margin	n/a

Dividends & Yields

RemeGen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.77%
Shareholder Yield	-0.77%
Earnings Yield	1.44%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3